DAVID E. LAZAR

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

TITAN PHARMACEUTICALS INC

Filing Date Source Excerpt
2023-05-19 David E. Lazar serves as Chief Executive Officer and Chairman of the Board... David E. Lazar 2022 compensation total $152,250.
2023-11-28 Mr. Lazar is our Chief Executive Officer and our former Chairman of the Board. The shares of common stock beneficially owned include 100,000 shares of common stock issuable pursuant to unreleased stock awards.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22